A detailed history of Black Rock Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Black Rock Inc. holds 29,107,548 shares of ALKS stock, worth $863 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,107,548
Previous 29,168,481 0.21%
Holding current value
$863 Million
Previous $790 Million 11.16%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $1.41 Million - $1.66 Million
-60,933 Reduced 0.21%
29,107,548 $701 Million
Q1 2024

May 10, 2024

SELL
$26.4 - $32.56 $22.5 Million - $27.8 Million
-853,946 Reduced 2.84%
29,168,481 $790 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $301 Million - $369 Million
12,861,170 Added 74.94%
30,022,427 $833 Million
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $7.38 Million - $8.69 Million
271,782 Added 1.61%
17,161,257 $481 Million
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $7.6 Million - $9.02 Million
268,222 Added 1.61%
16,889,475 $529 Million
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $4.99 Million - $5.72 Million
197,079 Added 1.2%
16,621,253 $469 Million
Q4 2022

Feb 13, 2023

BUY
$21.94 - $26.24 $20.5 Million - $24.6 Million
935,968 Added 6.04%
16,424,174 $429 Million
Q3 2022

Nov 14, 2022

SELL
$22.0 - $31.87 $6.57 Million - $9.52 Million
-298,654 Reduced 1.89%
15,488,206 $346 Million
Q2 2022

Aug 12, 2022

BUY
$26.4 - $30.54 $18.7 Million - $21.6 Million
706,814 Added 4.69%
15,786,860 $470 Million
Q1 2022

May 12, 2022

BUY
$23.07 - $27.99 $19.1 Million - $23.2 Million
827,759 Added 5.81%
15,080,046 $397 Million
Q4 2021

Feb 10, 2022

BUY
$21.47 - $32.08 $25 Million - $37.3 Million
1,163,567 Added 8.89%
14,252,287 $332 Million
Q3 2021

Nov 09, 2021

BUY
$23.37 - $32.13 $1.22 Million - $1.68 Million
52,174 Added 0.4%
13,088,720 $404 Million
Q2 2021

Aug 11, 2021

BUY
$18.78 - $25.15 $245 Million - $328 Million
13,036,546 New
13,036,546 $320 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.